Addus HomeCare Co. (NASDAQ:ADUS) Receives $133.67 Average Price Target from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has earned a consensus recommendation of “Buy” from the eleven research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have given a strong buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $133.67.

ADUS has been the topic of several recent research reports. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Finally, Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd.

Addus HomeCare Trading Up 0.3 %

Shares of NASDAQ ADUS opened at $124.59 on Wednesday. The stock has a market capitalization of $2.26 billion, a PE ratio of 28.51, a PEG ratio of 2.11 and a beta of 1.00. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.12. The stock has a fifty day simple moving average of $125.12 and a 200-day simple moving average of $125.83.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.03 EPS. On average, equities analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock worth $4,930,750 over the last 90 days. 4.60% of the stock is owned by insiders.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Addus HomeCare during the 3rd quarter worth approximately $1,622,000. Dimensional Fund Advisors LP increased its holdings in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. Point72 Asset Management L.P. raised its position in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Addus HomeCare by 136.5% during the 2nd quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock worth $9,294,000 after purchasing an additional 46,199 shares during the period. Finally, American Century Companies Inc. grew its position in Addus HomeCare by 90.6% during the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after purchasing an additional 8,743 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.